IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients

Clinical trial NCT06690359 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06690359
Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

IgA Nephropathy Membranous Nephropathy

Start date: 2024-12-13
Primary completion: 2025-08-04
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.